Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 19, 2025The Anatolian Journal of CardiologyOpen Access

Dysregulation of Serum miR-212-3p Serves as a Biomarker to Predict Disease Onset and Short-Term Prognosis in Acute Coronary Syndrome Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

BLBinyan LuoWDWen DuGJGaxue Jiang

Discussion

Loading...

Member takes

Overview

This analysis demonstrates the diagnostic utility of miR-212-3p in acute coronary syndrome, suggesting its role in predicting major adverse cardiovascular events.

Key Points

  • Elevated serum miR-212-3p levels in acute coronary syndrome patients highlight its potential as a non-invasive biomarker.
  • Serum miR-212-3p levels correlated significantly with major adverse cardiovascular events, indicating its prognostic value.
  • Diagnostic utility of miR-212-3p was evaluated through ROC curve analysis and logistic regression, demonstrating its effectiveness.
  • Independent risk factors for major adverse cardiovascular events include elevated miR-212-3p and established myocardial injury markers.

Cite This Study

Luo et al. (2025) studied this question.

synapsesocial.com/papers/68d466a831b076d99fa64e67https://doi.org/10.14744/anatoljcardiol.2025.5306
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comment on “Dysregulation of Serum miR-212- 3p Serves as a Biomarker to Predict Disease Onset and Short Term Prognosis in Acute Coronary Syndrome Patients”2026
  2. 2Downregulation of serum miR-30c-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients2025 · 5 citations
  3. 3Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention2022 · 16 citations
  4. 4Upregulation of Serum miRNA-3615 Serves as a Biomarker to Predict Disease Onset and Prognosis in Acute Coronary Syndrome Patients2026
  5. 5The diagnostic value of miR-338-3p in acute coronary syndrome and its correlation with MACE occurrence2026